Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex
Article first published online: 3 SEP 2002
DOI: 10.1002/syn.10131
Copyright © 2002 Wiley-Liss, Inc.
Additional Information
How to Cite
Berridge, C. W. and Stalnaker, T. A. (2002), Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex. Synapse, 46: 140–149. doi: 10.1002/syn.10131
Publication History
- Issue published online: 3 SEP 2002
- Article first published online: 3 SEP 2002
- Manuscript Accepted: 12 JUL 2002
- Manuscript Received: 29 MAR 2002
Funded by
- Public Health Service. Grant Numbers: DA10681, DA00389, MH14602
- Abstract
- References
- Cited By
Keywords:
- arousal;
- dopaminergic;
- noradrenergic;
- stimulants;
- waking;
- sleep;
- prefrontal cortex;
- narcolepsy;
- ADHD
Abstract
Despite the well-known and potent arousal-enhancing effects of amphetamine (AMPH)-like stimulants, the neurobiological substrates of AMPH-induced arousal have rarely been examined explicitly. Available evidence suggests the possible participation of noradrenergic and/or dopaminergic systems in the arousal-enhancing actions of AMPH-like stimulants. The current studies examined the extent to which low-dose AMPH-induced increases in waking are related to AMPH-induced increases in extracellular norepinephrine (NE) and dopamine (DA) levels within the prefrontal cortex (PFC), as measured by in vivo microdialysis. Vehicle injections elicited brief epochs of waking. Vehicle-induced waking was closely associated with a brief and moderate (50% above baseline) increase in NE levels. DA levels were less sensitive to the arousing actions of vehicle injections, with maximal increases of approximately 25% above baseline observed. 0.15 mg/kg and 0.25 mg/kg AMPH increased time spent awake, which resulted primarily from increases in quiet waking. Although the magnitude of the waking response did not differ substantially between the two doses across time, a trend for a more rapid recovery to baseline waking levels was observed at the higher dose, possibly suggesting the development of a relatively rapid-onset tolerance to the wake-promoting actions of AMPH at this dose. At the 0.15 mg/kg dose, AMPH elicited maximum increases of approximately 175% and 125% above baseline levels for NE and DA, respectively. The time course of AMPH-induced increases in waking closely paralleled the time course of AMPH-induced increases in both NE and DA efflux. These observations are consistent with the hypothesis that both increased DA and NE efflux contribute to the low-dose behavioral effects of AMPH-like stimulants, including the arousal-enhancing actions of these drugs. Additionally, these observations also suggest a possibly greater sensitivity of NE efflux, relative to DA, to moderately arousing conditions including low-dose AMPH-like stimulant administration. Synapse 46:140–149, 2002. © 2002 Wiley-Liss, Inc.

1098-2396/asset/SYN_centre.gif?v=1&s=8b68b53815a933ccf8cc46d912f270651ddf6fc8)
1098-2396/asset/cover.gif?v=1&s=4b9dcebb75fcbff0fdeec2b9792818249e8aa0f4)